1998至2013年美国胆道干预措施使用演变:一项全国性纵向研究结果
该研究利用美国全国住院患者样本,估算1998至2013年间诊断性ERCP、治疗性ERCP、胆管手术(BDS)和经皮肝穿刺胆管造影(PTC)的年龄标化使用趋势。总胆道干预从每10万人119.8降至100.1,诊断性ERCP下降76%,治疗性ERCP增加35%,BDS下降78%,PTC下降24%。ERCP已几乎完全取代手术治疗胆总管结石。
要点
- 总胆道干预从每10万人119.8降至100.1
- 诊断性ERCP下降76%,治疗性ERCP增加35%
- BDS下降78%,PTC下降24%
核心结论
- 尽管治疗性ERCP使用增加,但胆道干预总容量下降。
- BDS使用下降最显著,可能归因于ERCP治疗能力和安全性的提高。
- ERCP现在以治疗性为主。
- 大型城市医院引领从外科向消化内镜治疗胆道系统的转变。
研究设计与样本
- 利用美国全国住院患者样本,估算1998至2013年间诊断性ERCP、治疗性ERCP、BDS和PTC的年龄标化使用趋势。
- 计算这些操作的平均病死率、住院时间、患者人口学特征(年龄、性别、支付方)和医院特征(医院规模和都市状态)。
主要发现
- 总胆道干预从每10万人119.8降至100.1。
- 诊断性ERCP使用下降76%,治疗性ERCP使用增加35%。
- BDS率下降78%,PTC率下降24%。
- ERCP已几乎完全取代手术治疗胆总管结石。
- ERCP、BDS和PTC的病死率均下降,而平均住院时间保持稳定。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Bile duct surgery (BDS), percutaneous transhepatic cholangiography (PTC), and ERCP are alternative interventions used to treat biliary disease. Our aim was to describe trends in ERCP, BDS, and PTC on a nationwide level in the United States. METHODS: We used the National Inpatient Sample to estimate age-standardized utilization trends of inpatient diagnostic ERCP, therapeutic ERCP, BDS, and PTC between 1998 and 2013. We calculated average case fatality, length of stay, patient demographic profile (age, gender, payer), and hospital characteristics (hospital size and metropolitan status) for these procedures. RESULTS: Total biliary interventions decreased over the study period from 119.8 to 100.1 per 100,000. Diagnostic ERCP utilization decreased by 76%, and therapeutic ERCP utilization increased by 35%. BDS rates decreased by 78% and PTC rates by 24%. ERCP has almost completely supplanted surgery for the management of choledocholithiasis. Fatality from ERCP, BDS, and PTC have all decreased, whereas mean length of stay has remained stable. The proportion of Medicare-insured, Medicaid-insured, and uninsured patients undergoing biliary procedures has increased over time. Most of the increase in therapeutic ERCP and decrease in BDS occurred in large, metropolitan hospitals. CONCLUSIONS: Although therapeutic ERCP utilization has increased over time, the total volume of biliary interventions has decreased. BDS utilization has experienced the most dramatic decrease, possibly a consequence of the increased therapeutic capacity and safety of ERCP. ERCPs are now predominantly therapeutic in nature. Large urban hospitals are leading the shift from surgical to endoscopic therapy of the biliary system.
引用
- Huang RJ, Thosani NC, Barakat MT, et al. Evolution in the utilization of biliary interventions in the United States: results of a nationwide longitudinal study from 1998 to 2013. Gastrointest Endosc. 2017. PMID: 28062313. doi:10.1016/j.gie.2016.12.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。